Raymond Belanger Deloge

Mr. Raymond Belanger Deloge

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2022 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
HSHadley Stevens Smith
Hadley Stevens Smith
EBEmily S. Bonkowski
Emily S. Bonkowski
RDRaymond Belanger Deloge
Raymond Belanger Deloge
AGAmanda Gutierrez
Amanda Gutierrez
ARAlva M. Recinos
Alva M. Recinos
SPStacey Pereira
Stacey Pereira
Given that pediatric genomic sequencing (GS) may have implications for the health and well-being of both the child and family, a clearer understanding of the key drivers of the utility of GS from the family perspective is needed. The purpose of this study is to explore what is important to caregivers of pediatric patients regarding clinical GS, with a focus on family-level considerations. We conducted semi-structured interviews with caregivers (n = 41) of pediatric patients who had been recommended for or completed GS that explored the scope of factors caregivers considered when deciding whether to pursue GS for their child. We analyzed the qualitative data in multiple rounds of coding using thematic analysis. Caregivers raised important family-level considerations, in addition to those specifically for their child, which included wanting the best chance at good quality of life for the family, the ability to learn about family health, the impact on the caregiver’s well-being, privacy concerns among family members, and the cost of testing to the family. We developed a framework of key drivers of utility consisting of four domains that influenced caregivers’ decision making: underlying values, perceived benefits, perceived risks, and other pragmatic considerations regarding GS. These findings can inform measurement approaches that better capture the utility of pediatric GS for families and improve assessments of the value of clinical GS.

6 December 2022 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
RDRaymond Belanger Deloge
Raymond Belanger Deloge
XZXiaonan Zhao
Xiaonan Zhao
PLPamela N. Luna
Pamela N. Luna
CSChad A. Shaw
Chad A. Shaw
JRJill A. Rosenfeld
Jill A. Rosenfeld
DSDaryl A. Scott
Daryl A. Scott
Evidence suggests that genetic factors contribute to the development of anorectal malformations (ARMs). However, the etiology of the majority of ARMs cases remains unclear. Exome sequencing (ES) may be underutilized in the diagnostic workup of ARMs due to uncertainty regarding its diagnostic yield. In a clinical database of ~17,000 individuals referred for ES, we identified 130 individuals with syndromic ARMs. A definitive or probable diagnosis was made in 45 of these individuals for a diagnostic yield of 34.6% (45/130). The molecular diagnostic yield of individuals who initially met criteria for VACTERL association was lower than those who did not (26.8% vs 44.1%; p = 0.0437), suggesting that non-genetic factors may play an important role in this subset of syndromic ARM cases. Within this cohort, we identified two individuals who carried de novo pathogenic frameshift variants in ADNP, two individuals who were homozygous for pathogenic variants in BBS1, and single individuals who carried pathogenic or likely pathogenic variants in CREBBP, EP300, FANCC, KDM6A, SETD2, and SMARCA4. The association of these genes with ARMs was supported by previously published cases, and their similarity to known ARM genes as demonstrated using a machine learning algorithm. These data suggest that ES should be considered for all individuals with syndromic ARMs in whom a molecular diagnosis has not been made, and that ARMs represent a low penetrance phenotype associated with Helsmoortel-van der Aa syndrome, Bardet-Biedl syndrome 1, Rubinstein-Taybi syndromes 1 and 2, Fanconi anemia group C, Kabuki syndrome 2, SETD2-related disorders, and Coffin-Siris syndrome 4.

25 April 2023 in Children
Verified
Journal Article
Open access
PDF file
HSHadley Stevens Smith
Hadley Stevens Smith
EBEmily S. Bonkowski
Emily S. Bonkowski
MHMadison R. Hickingbotham
Madison R. Hickingbotham
RDRaymond Belanger Deloge
Raymond Belanger Deloge
SPStacey Pereira
Stacey Pereira
Families of children with rare and undiagnosed conditions face many psychosocial and logistical challenges that may affect their approach to decisions about their child’s care and their family’s well-being. As genomic sequencing (GS) is increasingly incorporated into pediatric diagnostic workups, assessing the family-level characteristics that shape the experience of pediatric GS is crucial to understanding how families approach decision-making about the test and how they incorporate the results into their family life. We conducted semi-structured interviews with parents and other primary caregivers of pediatric patients who were evaluated for a suspected genetic condition and who were recommended to have GS (n = 20) or who had recently completed GS (n = 21). We analyzed qualitative data using multiple rounds of thematic analysis. We organized our thematic findings into three domains of factors that influence the family-level experience of GS: (1) family structure and dynamics; (2) parental identity, relationships, and philosophies; and (3) social and cultural differences. Participants conceptualized their child’s family in various ways, ranging from nuclear biological family to support networks made up of friends and communities. Our findings can inform the design and interpretation of preference research to advance family-level value assessment of GS as well as genetic counseling for families.

19 July 2022 in Research Square
Verified
Preprint
Open access
PDF file
HSHadley Stevens Smith
Hadley Stevens Smith
EBEmily Bonkowski
Emily Bonkowski
RDRaymond Belanger Deloge
Raymond Belanger Deloge
AGAmanda Gutierrez
Amanda Gutierrez
ARAlva Recinos
Alva Recinos
SPStacey Pereira
Stacey Pereira
Given that pediatric genomic sequencing (GS) may have implications for the health and well-being of both the child and family, a clearer understanding of the key drivers of the utility of GS from the family perspective is needed. The purpose of this study is to explore what is important to caregivers of pediatric patients regarding clinical GS, with a focus on family-level considerations. We conducted semi-structured interviews with caregivers (n=41) of pediatric patients who had been recommended for or completed GS that explored the scope of factors caregivers considered when deciding whether to pursue GS for their child. We analyzed the qualitative data in multiple rounds of coding using thematic analysis. Caregivers raised important family-level considerations, in addition to those specifically for their child, which included wanting the best chance at good quality of life for the family, the ability to learn about family health, the impact on the caregiver’s well-being, privacy concerns among family members, and the cost of testing to the family. We developed a framework of key drivers of utility consisting of four domains that influenced caregivers’ decision making: underlying values, perceived benefits, perceived risks, and other pragmatic considerations regarding GS. These findings can inform measurement approaches that better capture the utility of pediatric GS for families.

21 March 2022 in Genetics in Medicine
Verified
Journal Article
Closed access
HSHadley Smith
Hadley Smith
EBEmily Bonkowski
Emily Bonkowski
RDRaymond Belanger Deloge
Raymond Belanger Deloge
AGAmanda Gutierrez
Amanda Gutierrez
ARAlva Recinos
Alva Recinos
SPStacey Pereira
Stacey Pereira

17 October 2026 in Molecular Therapy Advances
Verified
Journal Article
Open access
RDRaymond Belanger Deloge
Raymond Belanger Deloge
ASAbigail Sveden
Abigail Sveden
ZFZoë Frazier
Zoë Frazier
HOHailey Osika
Hailey Osika
CBCharlotte Byrne
Charlotte Byrne
Maya ChopraMaya Chopra
Maya Chopra